The Use of Olanzapine Versus Metoclopramide for the Treatment of Breakthrough Chemotherapy-Induced Nausea and Vomiting in Patients Receiving Highly Emetogenic Chemotherapy

被引：0
|
作者：
Navari, Rudolph [1 ,2 ]
Nagy, Cindy [1 ]
Gray, Sarah [2 ]
机构：
[1] Indiana Univ Sch Med, South Bend, IN USA
[2] Univ Notre Dame, Notre Dame, IN 46556 USA
来源：
PSYCHO-ONCOLOGY | 2013年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页码：31 / 31
页数：1
相关论文
共 50 条
  • [1] The use of olanzapine versus metoclopramide for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy
    Rudolph M. Navari
    Cindy K. Nagy
    Sarah E. Gray
    Supportive Care in Cancer, 2013, 21 : 1655 - 1663
  • [2] The use of olanzapine versus metoclopramide for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy
    Navari, Rudolph M.
    Nagy, Cindy K.
    Gray, Sarah E.
    SUPPORTIVE CARE IN CANCER, 2013, 21 (06) : 1655 - 1663
  • [3] The use of olanzapine versus metoclopramide for the treatment of breakthrough chemotherapy-induced nausea and vomiting (CINV) in patients receiving highly emetogenic chemotherapy.
    Navari, Rudolph M.
    Nagy, Cindy K.
    Gray, Sarah E.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [4] Aprepitant for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients receiving moderately emetogenic chemotherapy
    Takako Inoue
    Madoka Kimura
    Junji Uchida
    Kazumi Nishino
    Toru Kumagai
    Junko Taniguchi
    Fumio Imamura
    International Journal of Clinical Oncology, 2017, 22 : 600 - 604
  • [5] Aprepitant for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients receiving moderately emetogenic chemotherapy
    Inoue, Takako
    Kimura, Madoka
    Uchida, Junji
    Nishino, Kazumi
    Kumagai, Toru
    Taniguchi, Junko
    Imamura, Fumio
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2017, 22 (03) : 600 - 604
  • [6] The efficacy and safety of the addition of olanzapine to ondansetron and dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy
    Veerisa Vimolchalao
    Siwat Sakdejayont
    Ploytuangporn Wongchanapai
    Shama Sukprakun
    Pattama Angspatt
    Wilai Thawinwisan
    Piyachut Chenaksara
    Virote Sriuranpong
    Chanida Vinayanuwatikun
    Napa Parinyanitikun
    Nattaya Poovorawan
    Suebpong Tanasanvimon
    International Journal of Clinical Oncology, 2020, 25 : 396 - 402
  • [7] The efficacy and safety of the addition of olanzapine to ondansetron and dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy
    Vimolchalao, Veerisa
    Sakdejayont, Siwat
    Wongchanapai, Ploytuangporn
    Sukprakun, Shama
    Angspatt, Pattama
    Thawinwisan, Wilai
    Chenaksara, Piyachut
    Sriuranpong, Virote
    Vinayanuwatikun, Chanida
    Parinyanitikun, Napa
    Poovorawan, Nattaya
    Tanasanvimon, Suebpong
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2020, 25 (02) : 396 - 402
  • [8] Efficacy of antiemetic regimens for prevention and treatment of chemotherapy-induced nausea and vomiting in patients of breast cancer receiving highly emetogenic chemotherapy
    Vij, Soumya
    Dhasmana, Dilip Chander
    Bala, Suman
    Verma, Sanjiv Kumar
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2020, 41 (06) : 819 - 824
  • [9] Health-Related Quality of Life And Economic Analysis of Olanzapine Versus Aprepitant in Preventing Chemotherapy-Induced Nausea and Vomiting in Patients Receiving Highly Emetogenic Chemotherapy in Malaysia
    Badarudin, Nurul Suhaida
    Shah, Noraida Mohamed
    Tahir, Nurul Ain Mohd
    Ahmat, Azmi Nor Mohd Farez
    Ismail, Fuad
    Islahudin, Farida
    Yusak, Suhana
    Muhammad, Syahir
    Kassim, Kamarun Neasa Begam Mohd
    VALUE IN HEALTH REGIONAL ISSUES, 2024, 44
  • [10] Olanzapine for Preventing Nausea and Vomiting Induced by Moderately and Highly Emetogenic Chemotherapy
    Wang, Shi-Yong
    Yang, Zhen-Jun
    Zhang, Lu
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (22) : 9587 - 9592
12345